Medication info
Rosetive Tablet 10/20 mg

Rosetive Tablet 10/20 mg

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Albogene Korea Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
PTP - 30 tablets/PTP [(10 tablets/PTP x 3)], bottle - 30 tablets/bottle, bottle - 100 tablets/bottle
Approval status
Active

MFDS item code 201506785 · Approved 2015.09.24 · Insurance code 652604930

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg~10/20mg daily. The recommended initial dose is 10/5mg daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 10/20mg daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Ingredients

Manufacturer
Albogene Korea Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated apolipoprotein B
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication helps lower total cholesterol, LDL cholesterol, apolipoprotein B, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia, such as familial or non-familial hypercholesterolemia, and mixed dyslipidemia. It is used in conjunction with an appropriate diet and is administered as an adjunct when dietary control is insufficient. Additionally, in managing the risk of atherosclerotic vascular disease due to hypercholesterolemia, multiple risk factors should be considered in the treatment with lipid-modifying therapy. It is important to check for other secondary causes and provide appropriate treatments, with regular monitoring of cholesterol and triglyceride levels before and during treatment. This medication is effective for improving the patient's blood lipid status and contributes to reducing the risk of atherosclerotic vascular disease.

How to take

Adult dose

Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg~10/20mg daily. The recommended initial dose is 10/5mg daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 10/20mg daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Precautions

This medication may cause serious problems with muscles, so if sudden muscle pain or weakness occurs, inform your doctor immediately. In particular, it may be necessary to temporarily discontinue or stop taking this medication if there are risk factors such as severe infections, hypotension, major surgeries, trauma, or endocrine disorders. This medication should not be taken by those with allergies to it or liver or muscle disorders. Furthermore, patients with severe renal impairment, women who are pregnant or may become pregnant, and nursing mothers should not use this medication. Patients at high risk of myopathy, such as those with moderate renal impairment, hypothyroidism, a family history of muscle disease, alcoholics, and Asian patients, should use this medication with caution. Careful administration is also required for patients with poor liver function, those who consume large amounts of alcohol, the elderly, and those taking certain other medications. This medication may cause side effects such as liver dysfunction, dyspepsia, myalgia, headache, and edema, so consult your doctor if you experience unusual symptoms. It should be absolutely avoided during pregnancy due to potential harm to the fetus, and women of childbearing potential should be on appropriate contraception during treatment. Its safety and efficacy have not been established in children and adolescents, so it is not recommended. Regular liver and muscle function tests should be performed during treatment, and inform your healthcare provider about any medications you are currently taking due to potential interactions. There is no specific antidote for overdose, so symptomatic treatment and appropriate supportive care are necessary. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, dyspepsia, elevated ALT, edema, myalgia, elevated AST, headache, acute pyelonephritis, dry mouth, elevated liver enzymes, abnormal liver function tests, increased blood lactate dehydrogenase, pruritus, upper respiratory infection, elevated blood glucose, increased blood CPK, chest discomfort, dizziness, lethargy, neurodegenerative disorders, orthostatic dizziness, migraines, diabetes, impaired glucose tolerance, depression, bronchitis, rhinitis, cystitis, tinea unguium, soft tissue infection, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, elevated blood alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid droop, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, myasthenia gravis, ocular myasthenia, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, weakness, tremors, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disorder, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, hypoglycemia, anemia, splenomegaly, conjunctival injection, renal failure, liver dysfunction, increased blood creatinine, elevated blood pressure, increased blood urea, muscle cramps, gout, erectile dysfunction, syncope, generalized pain, fatigue, numbness, sensory changes, chest discomfort, loss of appetite, abdominal bloating

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and humidity, so it must be stored in a tightly sealed container. The storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature to ensure the safety of the medication's effectiveness.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

PTP - 30 tablets/PTP [(10 tablets/PTP x 3)], bottle - 30 tablets/bottle, bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.